Veneziani N, De Pasquale C, Baglietto M
Istituto di Cardiochirurgia, Università degli Studi di Bari.
Clin Ter. 1992 May;140(5):481-5.
The authors have evaluated the efficacy of short term treatment with an imipenem-cilastatin combination in a selected group of 72 patients undergoing implant or substitution of a pacemaker and with associated pathology potentially increasing the risk of infection. After 30 months' follow-up, the authors underline the efficacy and advantages of this treatment.
作者评估了亚胺培南-西司他丁联合用药短期治疗一组72例接受起搏器植入或置换且伴有可能增加感染风险相关病理状况患者的疗效。经过30个月的随访，作者强调了这种治疗方法的疗效和优势。
